Clinical Trial Update: BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries [NA]

View source ↗

Summary

A completed first-in-man trial evaluating Biotronik's paclitaxel-coated Passeo-18 Lux DRB balloon versus plain balloon angioplasty in infrapopliteal arteries fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Atherosclerosis
• Peripheral Artery Disease
• Vascular Disease

Drugs mentioned

• Passeo-18 Lux DRB (paclitaxel-coated balloon)

Snippet

Sponsor: Biotronik AG | Conditions: Atherosclerosis, Arteriosclerosis | NA | Status: COMPLETED